LAGEVRIO®
offering product urn:matchory:offering:01m772jz97erc8e17r5qe3a959
Offered by Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity). Relation: not stated. Commodity: 51343812 Glecaprevir/Pibrentasvir (commodity).
An offering's identity is its owner, its commodity and its normalised name; it is never merged with another supplier's.
Facts
| Attribute | Value as written | Producer | Evidence | Observed | Status |
|---|---|---|---|---|---|
| Name as stated name | LAGEVRIO® | products products 2 | LAGEVRIO®https://www.merck.com/wp-content/uploads/sites/124/2026/11/Public-Pipeline-4Q2026-Merck.pdf |
2026-11-12 | current |
| Name as stated name | LAGEVRIO® | extraction extract 3 | LAGEVRIO®https://www.merck.com/wp-content/uploads/sites/124/2026/11/Public-Pipeline-4Q2026-Merck.pdf |
2026-11-12 | current |
| UNSPSC classification unspsc | 51343812 (8 candidates considered) (0.91) | classification unspsc 3 | 2026-11-12 | current |